Home / Import refusals / SCS-3728327-7/10002/1

FDA Import Refusal SCS-3728327-7/10002/1 — ASTRAZENECA

ASTRAZENECA — FEI 3020813206

The FDA refused shipment SCS-3728327-7/10002/1 from ASTRAZENECA (India) on September 16, 2025. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 16, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118,3280

Other import refusals

  • AEK-7960283-3/10003/1 (Fri Dec 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9054909-6/10002/1 (Thu Dec 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7648528-6/20002/1 (Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7697916-8/20002/1 (Thu Oct 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7511982-4/10002/1 (Fri Sep 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources